A novel peptide RIFV suppresses human adipocyte differentiation through the inhibition of C/EBP-β expression

BACKGROUND: Obesity is a global epidemic disease that increases the risk of metabolic syndrome. However, therapeutic drugs for obesity are still scarce. In recent years, peptides have been identified as new biological regulators. RIFV (R-I-F-V-P-I-K-G-R-P-A-P), a novel active peptide from our peptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen, Shen, Dan, Li, Yun, Zhong, Hong, Wang, Xing, Cui, Xian-wei, Shi, Chun-Mei, Ji, Chen-Bo, Guo, Xi-Rong, Chen, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929371/
https://www.ncbi.nlm.nih.gov/pubmed/31889968
http://dx.doi.org/10.1186/s12986-019-0414-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929371/
https://www.ncbi.nlm.nih.gov/pubmed/31889968
http://dx.doi.org/10.1186/s12986-019-0414-z

Ejemplares similares